Work

A novel method for re-activating proliferation and differentiation in aged senescent human progenitor cells to increase regenerative potential

Year: 2019
Type: dissertation
Abstract: Aging impairs the function of adult progenitor cells, as evidenced by their increased senescence and decreasing regenerative capability, thus limiting their potential use in autologous graft for bonetissue engineering in the elderly. The current work has examined the use of adipose tissue derived progenitor cells from elderly donors, along with gingival tissue derived progenitor cells (ADCs and GDCs, respectively) for bone tissue regeneration. Single-cell sequencing confirmed the existence of progenitor cells in bulk isolated uncultured adipose tissue from an elderly donor(female, 76yrs), and five novel genes within this subpopulation were identified. Following this, cultured cells from ADCs were confirmed to have correlating cell surface expression for progenitor cell markers to that identified with sequencing. These markers included; PDGFRα, CD44, CD73, CD90, CD105, CD166 and STRO-1 (passage 0 only) while lacking expression of haematopoietic and endothelial markers: CD31, CD34, CD45. However, aging impaired the function of adult progenitor cells, demonstrated with increased senescence and decreasing regenerative capability in ADCs from elderly donors. This limited the potential use of aged progenitor cells in autologous graft for bone-tissue engineering in the elderly, the elderly being the demographic with the greatest demand for regenerative therapies. Studies therefore investigated whether senescent ADCs obtained from elderly human donors (≥60 yrs) could be re-activated to increase their regenerative potential. To achieve this, a novel method was developed in which aged ADCs were treated with CHIR99021 (3µM), an inhibitor of GSK3α/β, for 7 days and cultured in three-dimensional spheroid culture for a further 2 days. Results show CHIR99021 increased β-catenin nuclear localisation and Wnt target gene expression, including CCND1 (encoding cyclin D). Spheroid culture up-regulated the expression genes encoding the hypoxia inducible factors, VEGFA, BCL2 as well as CCND1, indicating a limited oxygen supply within the spheroids activated cell survival pathways. When combining CHIR99021 and spheroid culture for the novel protocol, proliferation of aged ADCs improved. Cells displayed telomere elongation, without undergoing tumorigenic transformation in vitro. Additionally, expression of senescence markers, p16, p21 and β-galactosidase decreased. This novel protocol significantly improved the differentiation potential of aged ADCs. Differentiation was significantly improved, demonstrated using osteogenic medium with upregulation of RUNX2, a key osteogenic marker. Similarly, lineage-specific markers for chondrogenesis and adipogenesis were significantly upregulated, including SOX9 and PPARG respectively. When applied to in vitro experimentally aged GDCs the re-activation protocol demonstrated a similar reversal of aging as seen with the ADCs. The novel protocol achieved a reversal of aging to the level demonstrated by young GDCs before experimental aging. Thus, this thesis has developed a novel approach for re-activating senescent cells, with implications for improved regenerative approaches for the elderly. Future work will focus on translating the in vitro results into an in vivo model for bone regeneration as a stepping stone for clinical application.
Language: English
Subfield: Cell Biology
Open Access status: green
OpenAlex ID: W7058391206
Cites: 310
Cited by:
Related to: 10